id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-D-3581-0001,FDA,FDA-2015-D-3581,"Homologous Use of Human Cells, Tissues, and Cellular and Tissue-Based Products; Draft Guidance for Industry and Food and Drug Administration Staff; Availability",Proposed Rule,GDL Guidance,2015-10-30T04:00:00Z,2015,10,2015-10-30T04:00:00Z,2016-04-30T03:59:59Z,2024-11-12T05:48:43Z,2015-27704,1,0,0900006481cfcaaa
FDA-2015-D-3581-0002,FDA,FDA-2015-D-3581,"Draft Guidance Homologous Use of Human Cells, Tissue, and Cellular and Tissue-Based Products",Other,Guidance,2015-10-30T04:00:00Z,2015,10,2015-10-30T04:00:00Z,,2024-11-07T23:28:54Z,,1,0,0900006481cf959a